PerceptiMed appoints Frank Starn CEO
The board of directors of PerceptiMed announced Tuesday that Frank Starn has been appointed chief executive officer. Citing the success the company is having with its scripClip pick-to-light will call system, Dr.
Pharmacy
Cardinal Health appoints Stephen Mason to lead medical segment
Cardinal Health announced Tuesday that Stephen Mason, president of the company’s Cardinal Health at-Home Solutions business, has been promoted to chief executive officer of Cardinal Health’s Medical segment.
NACDS praises Missouri’s e-prescribing Law
The National Association of Chain Drug Stores (NACDS) on Monday praised Missouri’s enactment of SB 514, which requires electronic prescriptions for controlled substances, with specified exceptions, effective January 1, 2021.
Rite Aid partners with Google Maps
CAMP HILL, Pa. – Rite Aid and The Rite Aid Foundation announced Monday that over 550 medication disposal units across the nation are now searchable on Google Maps, making it even easier for people to safely dispose of unneeded or unwanted medications.
HDA issues new report on Rx drug importation
A new report published by the HDA Research Foundation concludes that federal proposals to permit the importation of prescription drugs into the U.S. fail to provide comprehensive guidance and funding to meet current federal safety and quality standards.
Walgreens prepares for Tropical Storm Barry
Walgreens is taking proactive measures to assist customers, team members and communities currently in the projected path of Tropical Storm Barry, and is preparing to fully support any impacted regions in its aftermath.
Amneal announces restructuring and costs savings plan
Amneal Pharmaceuticals announced this week a comprehensive restructuring plan designed to reduce its cost base, further right size its organization and optimize its global manufacturing infrastructure.
204 pharmacy stakeholder groups urge senate finance to fix DIR
Support for pharmacy direct and indirect remuneration fee reform continues to grow, with 204 pharmacy stakeholder and patient advocacy groups urging the Senate Finance Committee to include pharmacy DIR fee reform in its forthcoming drug pricing legislation. Nearly a quarter of the U.S.
Smith Drug, PerceptiMed announce distributorship agreement
Smith Drug Co. has entered into a non-exclusive agreement to distribute the PerceptiMed, scripClip will-call system to pharmacies.
PBMs support transparency for consumers, health plan sponsors, policymakers
The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s action by the House Energy and Commerce Subcommittee on Health drug pricing transparency legislation: PCMA applauds the Energy and Commerce Subcommittee on Health for advancing legislation promoting real-
PCMA issues statement on proposed Rx drug rebate rule
Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Administration’s decision to withdraw the proposed rule on prescription drug rebates: “We understand that high prescription drug prices are a burden for too many Ame
Walgreens, Kaléo expand pharmacy program
Walgreens and Kaléo announced Thursday AUVI-q (epinephrine injection, USP) 0.1 mg auto-injector is available at Walgreens locations nationwide. AUVI-q 0.1 mg is the first and only epinephrine auto-injector (EAI) approved by the U.S.
Kroger Health teams up to launch depression treatment pilot
Kroger Health, the healthcare arm of The Kroger Co., announced its partnership with Myriad Genetics to pilot Myriad Genetics’ GeneSight pharmacogenomic test with Kroger Prescription Plan members. Nearly 500 Kroger pharmacies across five states will participate in the GeneSight pilot.
Dr. Reddy’s releases O-T-C store brand equivalent of Mucinex D extended release tablets
Dr. Reddy’s announced launch of an over-the-counter (O-T-C) store-brand equivalent of Mucinex D Extended Release Tablets in two strengths— guaifenesin 600 mg and pseudoephedrine HCl 60 mg, and guaifenesin 1200 mg and pseudoephedrine HCl 120 mg—in the United States market, as approved by the U.S.
Lilly reports new data indicating rise in opioid use for migraine treatment
Eli Lilly and Co. announced the upcoming presentation of data indicating rising rates of opioid use for the treatment of migraine based on results from the OVERCOME (Observational Survey of the Epidemiology, Treatment and Care of Migraine) study.